Programmed cell death in the developing heart

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 603-620

  Van Den Hoff, Maurice J B ^a   Van Den Eijnde, Stefan M ^b   Virágh, Szabolcs ^c   Moorman, Antoon F M ^a  

^a Laboratory for Physiology   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Dept Pathol Haynal Univ Hlth S ^*  (Hungary)

Author keywords

Apoptosis; Development biology; Embryology

Indexed keywords

DNA FRAGMENT; GROWTH FACTOR; PHOSPHATIDYLSERINE; TERATOGENIC AGENT;

APOPTOSIS; CELL DEATH; CELL MEMBRANE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONGENITAL HEART MALFORMATION; EMBRYOLOGY; HEART DEVELOPMENT; HUMAN; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENTIATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; CASPASES; CELL MEMBRANE; CHICKENS; DNA FRAGMENTATION; GESTATIONAL AGE; HEART; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA, HEART; PHOSPHATIDYLSERINES; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TERATOGENS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033959094     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00401-0     Document Type: Review

References (145)

1. Vaux D.L., Korsmeyer S.J. Cell Death in Development. Cell. 96:1999;245-254.
2. Glücksmann A. Cell deaths in normal vertebrate ontogeny. Biol. Rev. Camb. Philos. Soc. 26:1951;59-86.
3. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
4. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
5. Manasek F.J. Myocardial cell death in the embryonic chick ventricle. J. Embryol. Exp. Morph. 21:1969;271-284.
6. Krstic R., Pexieder T. Ultrastructure of cell death in bulbar cushions of chick embryo heart. Z. Anat. Entw. Gesch. 140:1973;337-350.
7. Pexieder T. Die quantitative Karte de Zellunterganges in der Herzentwicklung der Hühnerembryoenen swichen dem 2. und 8. Tag der incubation. Anat. Anz. 128:1971;295-302.
8. Pexieder T., Tissue dynamics of heart morphogenesis I. The phenomena of cell death. A identification and morphology. Z. Anat. Entwickl-Gesch. 137:1972;270-284.
9. Pexieder T., Tissue dynamics of heart morphogenesis I. The phenomena of cell death. B. Topography. Z. Anat. Entwickl-Gesch. 138:1972;241-253.
10. Pexieder T. Cell death in morphogenesis and teratigenesis of the heart. Adv. Anat. Embryol. Cell. Biol. 51:1975;1-99.
11. Okamoto N., Satow Y., Hidaka N., Akimoto N., Miyabara S. Morphogenesis of congenital heart anomaly: bulboventricular malformations. Jpn. Circ. J. 42:1979;1105-1120.
12. Okamoto N., Satow Y. Cell death in bulbar cushion of normal and abnormal developing heart. Lieberman M., Sano T. Developmental an physiological correlates of cardiac muscle. 1975;51-65 Raven Press, New York.
13. Okamoto N., Akimoto N., Satow Y., Hidaka N., Miyabara S. Role of cell death in conal ridges of developing human heart. Persp. Cardiovasc. Res. 5:1981;127-137.
14. Satow Y., Okamoto N., Akimoto N., Hidaka N., Miyabara S., Pexieder T. Comparative and morphometric study on genetically programmed cell death in rat and chick embryonic heart. Cardiovasc. Res. 5:1981;115-126.
15. Hurle J., Lafarga M., Ojeda J.L. Cytological and cytochemical studies of the necrotic area of the bulbus of the chick heart: phagocytosis by developing myocardial cells. J. Embryol. Exp. Morph. 41:1977;161-173.
16. Hurle J., Lafarga M., Ojeda J.L. In vivo phagocytosis by developing myocardial cells. An ultrastructural study. J. Cell Sci. 33:1978;363-369.
17. Hurle J.M., Ojeda J.L. Cell death during the development of the truncus and conus of the chick embryo heart. J. Anat. 129:1979;427-439.
18. Ojeda J.L., Hurle J.M. Cell death during the formation of the tubukar heart of the chick embryo. J. Embryol. Exp. Morph. 33:1975;523-534.
19. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
20. Wijsman J.H., Jonker R.C., Keijzer R., van de Velde C.J.H., Cornelisse C.J., van Dierendonck J.H. A method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41:1993;7-12.
21. Cohen J.J., Duke R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:1984;38-42.
22. Fadok V.A., Bratton D.L., Frasch S.C., Warner M.L., Henson P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Differentiation. 5:1997;551-562.
23. Koopman G., Reutlingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., van Oers M.H.J. Annexin V for flow cytometric detection of phosphatedylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
24. van den Eijnde S.M., Boshart L., Reutlingsperger C.P., De Zeeuw C.I., Vermeij-Keers C. Phosphatidylserine plasma membrane assymetry in vivo: apancellular phenomenon which alters during apoptosis. Cell Death Different. 4:1997;311-317.
25. van den Eijnde S.M., Luijsterberg A.J.M., Boshart L., De Zeeuw C.I., Reutlingsperger C.P., Vermeij-Keers C. In situ detection of apoptosis during embryogenesis with annexin V: from mount to ultrastructure. Cytometry. 29:1997;313-320.
26. van den Eijnde S.M., Boshart L., Baehrecke E.H., De Zeeuw C.I., Reutlingsperger C.P., Vermeij-Keers C. Phosphatidylserine exposure by apoptotic cells is phylogentically conserved. Apoptosis. 3:1998;9-16.
27. Kouroku Y., Urase K., Fujita E., Isahara K., Ohsawa Y., Uchiyama Y., Momoi M.Y., Momoi T. Detection of activated caspase-3 by a cleavage site-directed antiserum during naturally occuring DRG neurons apoptosis. Biochem. Biophys. Res. Commun. 247:1998;780-784.
28. Leers M.P., Kölgern W., Björklund B., Bergman T., Tribbick G., Persson B., Björklund P., Ramaekers F.C., Nap M., Jörnval H., Schutte B. Immunohistochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187:1999;567-572.
29. Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., Vinters H.V., Frautschy S.A., Cole G.M. Antibody to caspase cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152:1988;379-389.
30. Urase K., Fujita E., Miho Y., Kouroku Y., Mukasa T., Yagi Y., Momoi M.Y., Momoi T. Detection of activated caspase-3 (CPP32) in the vertebrate nervous system during development by a cleavage site-directed antiserum. Brain Res. 111:1998;77-87.
31. Clarke P.G.H., Clarke S. Nineteenth century research on naturally ocurring cell death and related phenomena. Anat. Embryol. 193:1996;81-99.
32. Manjo G., Joris I. Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146:1995;3-15.
33. Sun X.M., Snowden R.T., Skilleter D.N., Dinsdale D., Ormerod M.G., Cohen G.M. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal. Biochem. 204:1992;351-356.
34. Clarke P.G.H. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181:1990;195-213.
35. Ghyselinck N.B., Wendling O., Messaddeq N., Dierich A., Lampron C., Décimo D., Vilville S., Chambon P., Mark M. Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart. Dev. Biol. 198:1998;303-318.
36. Schweigel J.U., Merker H.J. The morphology of various types of cell death. Prenatal Tissue. 7:1973;253-266.
37. Labat-Moleur F., Guillermet C., Lorimier P., Robert C., Lanttuejoul S., Brambilla E., Negoescu A. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J. Histochem. Cytochem. 46:1998;327-334.
38. Devaux P.F. Static and dynamic lipid asymmetry in cell membranes. Biochem. J. 39:1991;1163.
39. McEnvoy L., Williamson P., Schlegel R.A. Membrane phospholipid asymmetry as a determant of erythrocyte recognition by macrophages. Proc. Natl. Acad. Sci. USA. 83:1986;3311-3315.
40. op den Kamp J.A.F. Lipid assymetry in membranes. Annu. Rev. Biochem. 48:1979;47-71.
41. Vermes I., Haanen C., Steffens-Nakken H., Reutlingsperger C.P. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescien labelled annexin V. J. Immunol. Meth. 184:1995;39-51.
42. Ham A., Reutlingsperger C.P.M., Hauptman R., Hemker H.C., Hermens W.T., Willems G.M. Binding of vascular anticoagulant (VACa) to planar phospholipid bilayers. J. Biol. Chem. 265:1990;4923-4928.
43. Schlaepfer D.D., Mehlman T., Burgess W.H., Haigler H.T. Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein. Proc. Natl. Acad. Sci. USA. 84:1987;6078-6082.
44. Tait J.F., Gibson D., Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-1, a member of the lipocortin family. J. Biochem. 264:1989;7944-7949.
45. van den Eijnde S.M., Lips J., Boshart L., Vermeij-Keers C., Reutlingsperger C.P., De Zeeuw C.I. Spatiotemporal distribution of dying neurons during early mouse development. Eur. J. Neurosci. 11:1999;712-724.
46. Ya J., van den Hoff M.J.B., de Boer P.A.J., Tesink-Taekema S., Franco D., Moorman A.F.M., Lamers W.H. The normal development of the outflow tract in the rat. Circ. Res. 82:1998;464-472.
47. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272:1997;17907-17911.
48. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., Banach D., Ghayur T., Brady K.D., Wong W.W. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:1997;9677-9682.
49. Watanabe M., Choudry A., Berlan M., Singal A., Siwik E., Mohr S., Fisher S.A. Developmental remodeling and shortening of the cardiac outflow tract involves programmed cell death. Development. 125:1998;3809-3820.
50. Yue T.L., Wang C., Romanic A.M., Kikly K., Keller P., DeWolf W.E.J., Hart T.K., Thomas J.C., Storer B., Gu J.L., Wang X., Feuerstein G.Z. Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. J. Mol. Cell. Cardiol. 30:1998;495-507.
51. Cheng G, Wessels A, Gourdie RG, Thompson RP. The spatiotemporal distribution of apoptosis in developing chicken heart, 1999:submitted.
52. Poelman R.E., Mikawa T., Gittenberger-de Groot A.C. Neural crest cells in outflow tract septation of the embryonic chicken herat: differentiation and apoptosis. Dev. Dyn. 212:1998;373-384.
53. Poelman R.E., Gittenberger-de Groot A.C. A subpopulation of apoptosis-prone cardiac neural crest cells targets to the venous pole: multiple functions in heart development. Dev. Biol. 207:1999;271-286.
54. Takeda K., Yu Z.X., Nishikawa T., Tanaka M., Hosoda S., Farrans V.J. Kasajima: Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J. Mol. Cell Cardiol. 28:1996;209-215.
55. Moorman AFM, van den Hoff MJB, de Jong F, Franco D, Lamers WH. Myocardialization: A novel mechanism of cardiac septation, Fifth International Symposium on Etiology and Morphogenesis of Congenital Heart Disease, Tokyo, 1998, 1999:in press.
56. van den Hoff M.J.B., Moorman A.F.M., Ruijter J.M., Lamers W.H., Bennington R.W., Markwald R.R., Wessels A. Myocardialization of the cardiac outflow tract. Dev. Biol. 212:1999;477-490.
57. de Jong F., Virágh Sz., Moorman A.F.M. Cardiac Development: a morphologically integrated molecular approach. Cardiology in the Young. 7:1997;131-146.
58. Franco D., Markman M.W.M., Wagenaar G.T.M., Ya J., Lamers W.H., Moorman A.F.M. Myosin light chain 2A and 2V identifies the embryonic outflow tract myocardium in the developing rodent heart. Anat. Rec. 254:1999;135-146.
59. Pexieder T. Conotruncus and its septation at the advent of the molecular biology era. Clark E.B., Markwald R.R., Takao A. Developmental mechanisms of heart disease. 1995;227-247 Futura Publishing Co., Inc, Armonk, N.Y.
60. Chan-Thomas P.S., Thompson R.P., Robert B., Yacoub M.H., Barton P.J.R. Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick. Dev. Dyn. 197:1993;203-216.
61. Wessels A., Vermeulen J.L.M., Verbeek F.J., Virágh Sz., Kálmán F., Lamers W.H., Moorman A.F.M. Spatial distribution of 'tissue-specific' antigens in the developing human heart and skeletal muscle: III. An immunohistochemical analysis of the distribution of the neural tissue antigen G1N2 in the embryonic heart; implications for the development of the atrioventricular conduction system. Anat. Rec. 232:1992;97-111.
62. Moorman A.F.M., de Jong F., Denyn M.M.F.J., Lamers W.H. Development of the Cardiac Conduction System. Circ. Res. 82:1998;629-644.
63. Moorman A.F.M., Lamers W.H. Development of the conduction system of the vertebrate heart, in anonymous heart development. 1999;195-207 Academic Press, Boston.
64. Ferguson M.W. Palate development. Development. 103:1988;41-60.
65. Vermeij-Keers C., Mazzola R.F., van der Meulen J.C., Strickler M. Cerebrocraniofacial and craniofacial malformations: an embryological analysis. Cleft Palate J. 20:1983;128-145.
66. Hamburger V., Hamilton J.L. A series of normal stages in the development of the chick embryo. J. Morphol. 88:1951;49-92.
67. Sokal E.M., Trivedi P., Cheeseman P., Portmann B., Mowat A.P. The application of quantitative cytochemistry to study the acinar distribution of enzymic activities in human biopsy sections. J. Hepatol. 9:1989;42-48.
68. Parker T.G., Packer S.E., Schneider M.D. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:1990;507-514.
69. Arguello C., Delacruz M.V., Sanchez C. Ultrastructural and experimental evidence of myocardial cell differentiation into connective tissue cells in embryonic chick heart. J. Mol. Cell Cardiol. 10:1978;307-315.
70. Thompson E.B. Special topic: apoptosis. Annu. Rev. Physiol. 60:1998;525-531.
71. Adams J.M., Corey S. The bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
72. Ashkenazi A., Dixit V. Death receptor: signalling and modulation. Science. 281:1998;1305-1308.
73. Ashkenazi A., Dixit V. Apoptosis control by death and decoy receptor. Curr. Opin. Cell Biol. 11:1999;255-260.
74. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
75. Earnshaw W.C. A cellular poison cupboard. Nature. 397:1999;387-389.
76. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
77. Kidd V.J. Proteolytic activities that mediate apoptosis. Annu. Rev. Physiol. 60:1998;533-573.
78. Li H., Yuan J. Deciphering the pathways of life and death. Curr. Opin. Cell Biol. 11:1999;261-266.
79. Meldrum D.R. Tumor necrosis facto in the heart. Am. J. Physiol. 274:1998;R577-R595.
80. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
81. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem Sci. 22:1997;299-306.
82. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
83. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signalling mechanisms. Annu. Rev. Immunol. 17:1999;331-367.
84. Zachowski A., Herrman A., Paraf A., Devaus P.F. Phospholipid ouside-inside translocation in lymphocyte plasma membranemis a protein-mediated phenomenon. Biochim. Biophys. Acta. 897:1987;197-200.
85. Verhoven B., Schlegel R.A., Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1995;1597-1601.
86. Savill J.I.D., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today. 14:1993;131-136.
87. Savill J.I.D. Phagocytic docking with shocking. Nature. 392:1998;442-443.
88. Amahd M., Srinivasula S.M., Hedge R., Mukattash R., Fernandes-Alnemri T., Alnemri E.S. Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res. 58:1998;5201-5205.
89. Hu S., Snipas S.J., Vincenz C., Salvesen G., Dixit V. Caspase-14 is a novel developmentally regulated protease. J. Biol. Chem. 273:1998;29648-29653.
90. Humke E.W., Ni J., Dixit V. ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 273:1998;15702-15707.
91. Schotte P., Criekinge W., van de Craen M., van Loo G., Desmedt M., Grooten J., Cornelissen M., de Ridder L., Vandekerckhove J., Fiers W., van den Abeele P., Beyaert R. Cathepsin B-mediated activation of proinflammatory caspase-11. Biochem. Biophys. Res. Commun. 251:1998;379-387.
92. van de Craen M., van den Abeele P., Declercq W., van den Brande I., van Loo G., Molemans F., Schotte P., van Crienking W., Beyaert R., Fiers W. Characterization of seven murine caspase family members. FEBS Lett. 403:1997;61-69.
93. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
94. Kuida K., Zheng T.S., Na S., Kuan C.Y., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
95. Ng P.W.P., Porter A.G., Jänicke R.U. Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10. J. Biol. Chem. 274:1999;10301-10308.
96. Vincenz C., Dixit V. Fas-associated death domain protein interlekin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signalling. J. Biol. Chem. 272:1997;6578-6583.
97. Jiang Y. Woronicz, Liu W., Goeddel D.V., Prevention of constitutive TNF receptor 1 signalling by silencer of death domains. Science. 283:1999;543-546.
98. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
99. Goeddel D.V., Takeuchi M. The tumor necrosis factor receptor 2 signal transducers TRAF2 and cIAP1 are components of the tumor necrosis factor receptor 1 signalling complex. Proc. Natl. Acad. Sci. 93:1996;13973-13978.
100. McCarthy J.V., Ni J., Dixit V. RIP2 is an novel NF-κB activating and cell death-inducing kinase. J. Biol. Chem. 273:1998;16968-16975.
101. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
102. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signalling transduction pathways. Cell. 84:1996;299-308.
103. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor signalling complex. Immunity. 4:1996;387-396.
104. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signalling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
105. Sun X., Lee J., Navas T., Baldwin D.T., Stewart T.A., Dixit V. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274:1999;16871-16875.
106. Ting A.T., Pimentel-Muiños F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO1-initiated apoptosis. EMBO J. 15:1996;6189-6196.
107. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
108. Varfolomeev E.E., Schuchmann M.L.V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonia P., Wallach D. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276.
109. Zhang J., Liu X., Scherer D.C., van Kaer L., Wang X.D., Xu M. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc. Natl. Acad. Sci. USA. 95:1998;12480-12485.
110. Strasser A., Newton K. FADD/Mort1, a signal transducer that can promote cell death or cell growth. Int. J. Biochem. Cell Biol. 31:1999;533-537.
111. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mithochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
112. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., Gruss P. Apaf1 (CED4 homolog) regulates programmed cell death in mammalian development. Cell. 94:1993;727-737.
113. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
114. 2+, calcineurin and NF-AT. Cell. 96:1999;611-614.
115. Linette G.P., Li Y., Roth K., Korsmeyer S.J. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NF-AT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:1996;9545-9552.
116. Shibaski F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions with calcineurin and bcl-2. Nature. 386:1997;728-731.
117. de la Pompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Potter J., Wakeham A., Marengere L., Langille B.L., Crabtree G.R., Mak T.W. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 392:1998;182-185.
118. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., Charles de la Brousse F., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 392:1998;186-190.
119. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP Kinases on apoptosis. Science. 270:1995;1326-1331.
120. Kummer J.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20490-20494.
121. Wollert K.C., Chien K.R. Cardiotrophin-1 and the role of gp130-dependent signalling pathways in cardiac growth and development. J. Mol. Med. 75:1997;492-501.
122. Mjaatvedt C.H., Yamamura H., Wessels A., Ramdell A., Turner D., Markwald R.R. Mechanisms of segmentation, septation, and remodeling of the tubular heart: Endocrinal cushion fate and cardiac looping. Harvey R.P., Rosenthal N. Heart development. 1999;195-208 Academic Press, San Diego.
123. Kirby M.L. Contribution of neural crest to heart and vessel morphology. Harvey R.P., Rosenthal N. Heart development. 1999;179-193 Academic Press, San Diego.
124. Thomas T., Kurihara H., Yamagishi H., Kurihara Y., Yazaki Y., Olson E.N., Srvastava D. A signalling cascade involving endothelin-1, dHand and Msx1 regulates development of neural-crest-derived branchial arch mesenchyme. Development. 125:1998;3005-3014.
125. Srivastava D. Segemental regulation of cardiac development by the basic helix-loop-helix transcription factors d Hand and e Hand. Harvey R.P., Rosenthal N. Heart development. 1999;143-155 Academic Press, San Diego.
126. Soriano P. The PDGFα receptor is required for neural crest cell development and normal patterning of the somites. Development. 124:1997;2691-2700.
127. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFβ2 konockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development. 124:1997;2659-2670.
128. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yosida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:1996;407-411.
129. Hirota H., Chen J., Betz U.A.K., Rajewsky K., Gu Y., Ross J. Jr., Müller W., Chien K.R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell. 97:1999;189-198.
130. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1998;1067-1076.
131. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V. FADD, a novel death domain-containing protein, interacting with the death domain of Fas and intiating apoptosis. Cell. 81:1995;505-512.
132. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediated the TNF-induced NF-κB signal. Immunity. 8:1998;297-303.
133. Stanger B.Z., Leder P., Lee T.H., Kim E., Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO1 (CD95) in yeast and causes cell death. Cell. 81:1995;513-523.
134. Duan H., Dixit V. RAIDD is a new 'death' adaptor molecule. Nature. 385:1997;86-89.
135. Bergeron L., Perez G.I., MacDonald G., Shi L., Jurisicova A., Varmuza S., Latham K.E., Flaws J.A., Salter J.C.M., Hara H., Moskowitz M.A., Li A., Greenberg A., Tilly J.L., Yuan J. Defects in the regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1998;1304-1314.
136. Boise L.H., Gonzáles-Garcia M., Postema C.H., Ding L., Lindsten T., Turka L.A., Mao X., Nuñez G., Thompson C.B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
137. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
138. Gibson L., Holmgreen S.P., Huang D.C.S., Bernard O., Copeland N.G., Jenkins N.A., Sutherland G.R., Baker E., Adams J., Cory S. Bcl-w, a new member of the Bcl-2 family, promotes cell survival. Oncogene. 13:1996;665-675.
139. Print C.G., Loveland K.L., Gibson L., Meehan T., Stylianou A., Wreford N., de Kretser D., Metcalf D., Köntgen F., Adams J.M., Corey S. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl. Acad. Sci. USA. 95:1998;12424-12431.
140. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1995;1506-1510.
141. Knudson C.M., Tung K.S.K., Tourtellotte W.G., Brown G.A.J., Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 270:1995;96-99.
142. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death. Cell. 74:1993;609-619.
143. Xiang J., Chao D.T., Korsmeyer S.J. Bax-induced cell death may not require interleukin 1b-converting-enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559-14563.
144. Kurihara Y., Kurihara H., Oda H., Maemura K., Nagai R., Ishikawa T., Yazaki Y. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J. Clin. Invest. 96:1995;293-300.
145. Donovan M.J., Hahn R., Tessarollo L., Hempstead B.L. Identification of an essential nonneural function of neurotrophin 3 in mammalian cardiac development. Nat. Genet. 14:1996;210-213.